Prof. Biana Godin earned her Ph.D. in Pharmaceutical Sciences from the School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel. During her Ph.D. studies, Dr. Godin focused on designing a non-invasive treatment for the hard-to-treat deep skin infections and on nasal delivery of proteins. She completed postdoctoral fellowship in Cancer Nanotechnology at the Institute of Molecular Medicine, University of Texas Health Sciences Center in Houston. Her postdoctoral research focused on design and evaluation of injectable nanotherapies for cancer treatment and imaging. Dr. Godin is a Scientist in the Department of Nanomedicine at Houston Methodist Research Institute. Current research in Dr. Godin's lab, funded by federal, state and foundation grants, focuses on developing physiologically relevant in vitro and in vivo disease models and exploiting physical and biological mechanisms to improve currently available therapeutic options in oncology, infectious diseases and obstetrics. Dr. Godin is a translational scientist on the interception of biological and physical sciences, with the ultimate goal of bringing advanced and safe therapies and therapy personalization methods into the clinic to benefit patients. Dr. Godin has > 200 scientific publications, received multiple federal and foundation-based grants and participates in national and international grant review panels. She holds academic positions at the Department of Nanomedicine and Department of Obstetrics and Gynecology in the Institute of Academic Medicine, Houston Methodist Research Institute, Cancer Center Houston Methodist Hospital, as well as Adjunct Faculty at the Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center School of Medicine and Department of Biomedical Engineering, Texas A&M.